Zobrazeno 1 - 10
of 137
pro vyhledávání: ''
Autor:
Jianhua Feng, Kang Yu, Yisha Huang, Qianying Zhang, Yu Zhang, Yiyun Feng, Kanchun Dai, Deeksha Bhardwaj
Publikováno v:
Cancer Investigation. 39:550-558
This study aimed to examine the prognostic significance of peripheral absolute monocyte count (AMC) in combination with absolute lymphocyte count (ALC) at the time of relapse in a cohort of 57 patients with early relapsed (first complete remission12
Autor:
Kadir Eser, Pinar Saip, Erdem Cubukcu, Fuat Demirelli, Ozkan Alan, Zuleyha Calikusu, Aykut Bahceci, Ali Alkan, Hacer Demir, Mahmut Büyükşimşek, Cemile Karadeniz, Erhan Gokmen, Naziye Ak, Mehmet Bilici, Altay Aliyev, Turkkan Evrensel, Oznur Bal, Atakan Demir, Özge Keskin, Nilgün Yildirim, Saadettin Kilickap, Semra Paydas, Atike Gökçen Demiray, Kezban Nur Pilanci, Ali Gökyer, Perran Fulden Yumuk, Birol Yildiz, Duygu Ilke Cikman, Ismail Beypinar, Taner Korkmaz, Sinan Yavuz, Burcu Çakar, Erkan Arpaci, Gulsah Seydaoglu, Ferhat Ferhatoglu, Ahmet Z. Sahin, Gulcan Bulut, Serkan Degirmencioglu, Cengiz Karacin, Mutlu Dogan, Havva Yesil Cinkir, Kerem Okutur, Semiha Urvay, Deniz Işik, Melih Simsek, Osman Kostek, Meltem Baykara, Salim Basol Tekin, Deniz Yamac
Publikováno v:
Cancer Investigation. 39:473-481
Aim: The aim of this study is to evaluate the efficacy and toxicity of trastuzumab emtansine (T-DM1) in cases with metastatic breast cancer (mBC) in different lines of treatment. Method: Retrospective analysis of T-DM1 results of human epidermal grow
Publikováno v:
Cancer Investigation. 38:565-571
To assess clinicopathological characteristics and prognostic value of age stratification on overall survival (OS) and cancer-specific survival (CSS) for stage IV oral tongue squamous cell carcinoma.A total of 1357 patients were extracted from the SEE
Autor:
Yoshiki Negi, Yasuhiro Nakajima, Takashi Yokoi, Kozo Kuribayashi, Takashi Kijima, Toshiyuki Minami, Ryo Takahashi, Hirotoshi Ishigaki, Kazuhiro Kitajima, Hiroshi Doi, Akio Tada
Publikováno v:
Cancer Investigation. 38:356-364
Pleural effusion adenosine deaminase (ADA) levels are elevated in various diseases. We investigated whether pleural effusion ADA levels differ among patients with malignant pleural mesothelioma (MPM), lung cancer (LC), and benign diseases, including
Autor:
Eric H. Bernicker, Bin S. Teh, Jun Zhang, E. Brian Butler, Shraddha M. Dalwadi, Andrew M. Farach
Publikováno v:
Cancer Investigation. 37:506-511
With modern radiotherapy, stage I non-small cell lung cancer (S1NSCLC) cure is extended to nonsurgical candidates. Despite this, some S1NSCLC remains untreated. We aim to identify factors associated with no treatment. 62,213 S1NSCLC cases were identi
Autor:
Mansoureh Dehghani, Pejman Porouhan, Mona Ariamanesh, Farbod Hatami, Somayeh Ashkar Tizabi, Gary H. Lyman, Babak PeyroShabany, James S Welsh, Seyed Alireza Javadinia, Maryam Nabavifard, Danial Fazilat-Panah, Ahmad Ghasemi
Publikováno v:
Cancer investigation. 40(2)
Patients with cancer are at significantly greater risk of COVID-19 and its complications than the general population. Since IgG antibodies remain detectable well after infection with the SARS-CoV-2 virus, seroprevalence can be used to estimate the pr
Publikováno v:
Cancer investigation. 39(6-7)
The strong association between inflammation and cancer is reflected by the high interleukin-6 (IL-6) levels in the tumor microenvironment, where it promotes carcinogenesis by regulating all hallmarks of cancer and multiple signaling pathways. In this
Publikováno v:
Cancer investigation. 39(10)
Purpose We assessed real-world spectrum and patterns of irAEs for patients treated with anti-PD(L)1 ICIs. Methods irAEs were defined using medical and pharmacy claims for patients enrolled in a Medicare Advantage Prescription Drug plan who initiated
Autor:
Almudena Maria Cascales-Garcia, Marie-Christine Mathieu, Chafika Mazouni, Sofia Rivera, Ariane Dunant, Rodrigo Arriagada, Mauro Loi, Eric Deutsch, Sahar Ghith, Barbara Pistilli
Publikováno v:
Cancer Investigation. 37:29-38
Purpose To assess predictors of outcome in a cohort of Inflammatory Breast Cancer (IBC) patients receiving induction chemotherapy followed by local treatment. Methods We retrospectively reviewed 95 non-metastatic IBC patient files. Results Complete c
Publikováno v:
Cancer Investigation. 36:424-430
It is not clear whether sequential chemotherapy can be performed immediately in patients with p-stage I non-small cell lung cancer recurring during a 2-year period of daily oral administration with tegafur-uracil (UFT) as postoperative adjuvant chemo